Saturday, November 21, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Carl Zeiss Meditec Stock: Plunges Amid Weak Growth

Andreas Sommer by Andreas Sommer
August 7, 2025
in Stocks
0
Carl Zeiss Meditec Stock
0
SHARES
85
VIEWS
Share on FacebookShare on Twitter

Carl Zeiss Meditec’s shares plummeted by approximately 13% to €41.68 following its quarterly earnings report, despite posting a 7.6% revenue increase to €1.6 billion over nine months. The decline reflects investor disappointment over weak organic growth, which stood at just 1.1% after excluding acquisitions and currency effects. The company faced significant headwinds, including new U.S. tariffs and unfavorable exchange rates, which slashed pre-tax profits by 26% to €126.7 million. While adjusted earnings per share dipped from €1.35 to €1.24, the operational business showed resilience, with EBITA rising 3.1% to €175.4 million.

Mixed Performance Across Segments

The medical technology firm reported a stark divide between its segments: Microsurgery grew by 10%, while the larger Ophthalmology division stagnated. Geographically, Europe and Asia-Pacific saw gains, but the Americas recorded a decline. Despite a 23.3% surge in orders, analysts remain cautious, citing risks to the full-year outlook. Management reaffirmed its forecast, targeting moderate revenue growth and stable EBITA margins, though further currency volatility could pose challenges. Investors, however, remain wary, as the sharp stock drop underscores concerns over profitability.

Ad

Carl Zeiss Meditec Stock: Buy or Sell?! New Carl Zeiss Meditec Analysis from November 20 delivers the answer:

The latest Carl Zeiss Meditec figures speak for themselves: Urgent action needed for Carl Zeiss Meditec investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 20.

Carl Zeiss Meditec: Buy or sell? Read more here...

Tags: Carl Zeiss Meditec
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Eli Lilly Stock
Stocks

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

November 18, 2025
Micron Stock
Stocks

Micron Shares Approach Peak: What Comes After the AI Rally?

November 18, 2025
Varonis Stock
Stocks

Varonis Shares Plunge Amidst Mixed Signals

November 18, 2025
Next Post
Scout Stock

Scout Stock: Strong Earnings Meet Investor Caution

Uber Stock

Uber Stock: Analysts Bullish Despite Volatility

Sunrun Stock

Sunrun Stock: Soaring on Stellar Earnings and Upgraded Forecasts

Recommended

Hellofresh Stock

A Vote of Confidence: HelloFresh Insider Buys Amid Steep Share Decline

8 months ago
Ondas Holdings Stock

Ondas Holdings Strengthens Defense Sector Ambitions with Key Board Appointment

9 months ago
Lincoln National Stock

Lincoln National’s Q2 Earnings Beat Overshadows Revenue Concerns

1 year ago
TKMS Stock

TKMS Nears Final Approval for Landmark Indian Submarine Contract

8 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Home Depot Beats, Shares Slip: Bigger Tickets, Fewer Customers

Rotation, Not Panic: Retailers Test Where Tech’s Money Went

At 5.15%, the 10-Year Treasury Picks the Winners

Bitcoin Slips Below $70,000, and a Samsung Rumor Lifts Modine

Huang Exits, Cisco Reports: Who Actually Gets Paid for AI

The AI Rebound Gets an Audit: Who Earns, Who Borrows

Trending

Nvidia Stock
Newsletter

Anthropic Lists at a Premium, but the Sell-Off Keeps Going

by Stephanie Dugan
November 20, 2026
0

Dear readers, Yesterday's open question was whether the largest IPO on record could steady a falling tech...

Bitcoin Stock

Anthropic’s $81 Billion IPO Meets a Market in Need of Good News

November 19, 2026
Nvidia Stock

Nvidia Posts a Record Quarter, but Rate-Hike Fears Still Set the Tone

November 18, 2026
Home Depot Stock

Home Depot Beats, Shares Slip: Bigger Tickets, Fewer Customers

November 17, 2026
Bitcoin Stock

Rotation, Not Panic: Retailers Test Where Tech’s Money Went

November 16, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Anthropic Lists at a Premium, but the Sell-Off Keeps Going
  • Anthropic’s $81 Billion IPO Meets a Market in Need of Good News
  • Nvidia Posts a Record Quarter, but Rate-Hike Fears Still Set the Tone

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com